ENST00000363593.2:n.20C>T
Variant names:
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The ENST00000363593.2(SNORD118):n.20C>T variant causes a non coding transcript exon change. The variant allele was found at a frequency of 0.0000405 in 764,750 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000041 ( 0 hom. )
Consequence
SNORD118
ENST00000363593.2 non_coding_transcript_exon
ENST00000363593.2 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: 4.07
Publications
3 publications found
Genes affected
SNORD118 (HGNC:32952): (small nucleolar RNA, C/D box 118)
TMEM107 (HGNC:28128): (transmembrane protein 107) This gene encodes a transmembrane protein and component of the primary cilia transition zone. The encoded protein regulates ciliogenesis and ciliary protein composition. Human fibroblasts expressing a mutant allele of this gene exhibit reduced numbers of cilia, altered cilia length, and impaired sonic hedgehog signaling. In human patients, different mutations in this gene cause different ciliopathies, including Meckel-Gruber syndrome and orofaciodigital syndrome. [provided by RefSeq, May 2017]
TMEM107 Gene-Disease associations (from GenCC):
- Meckel syndrome 13Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- ciliopathyInheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
- Meckel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- orofaciodigital syndrome 16Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.15).
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SNORD118 | ENST00000363593.2 | n.20C>T | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 | NR_033294.2 | ||||
| TMEM107 | ENST00000437139.7 | c.*634C>T | 3_prime_UTR_variant | Exon 5 of 5 | 1 | NM_183065.4 | ENSP00000402732.2 | |||
| TMEM107 | ENST00000449985.6 | c.*683C>T | 3_prime_UTR_variant | Exon 2 of 2 | 1 | ENSP00000404753.2 | ||||
| TMEM107 | ENST00000532998.5 | c.*2120C>T | downstream_gene_variant | 2 | ENSP00000433148.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152152Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
6
AN:
152152
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000302 AC: 7AN: 231710 AF XY: 0.0000313 show subpopulations
GnomAD2 exomes
AF:
AC:
7
AN:
231710
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000408 AC: 25AN: 612598Hom.: 0 Cov.: 0 AF XY: 0.0000358 AC XY: 12AN XY: 334808 show subpopulations
GnomAD4 exome
AF:
AC:
25
AN:
612598
Hom.:
Cov.:
0
AF XY:
AC XY:
12
AN XY:
334808
show subpopulations
African (AFR)
AF:
AC:
0
AN:
17672
American (AMR)
AF:
AC:
0
AN:
43602
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
20976
East Asian (EAS)
AF:
AC:
1
AN:
36054
South Asian (SAS)
AF:
AC:
3
AN:
69708
European-Finnish (FIN)
AF:
AC:
0
AN:
37746
Middle Eastern (MID)
AF:
AC:
0
AN:
4142
European-Non Finnish (NFE)
AF:
AC:
18
AN:
349718
Other (OTH)
AF:
AC:
3
AN:
32980
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74328 show subpopulations
GnomAD4 genome
AF:
AC:
6
AN:
152152
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74328
show subpopulations
African (AFR)
AF:
AC:
1
AN:
41436
American (AMR)
AF:
AC:
0
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5200
South Asian (SAS)
AF:
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
5
AN:
68020
Other (OTH)
AF:
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Leukoencephalopathy with calcifications and cysts Pathogenic:1Uncertain:1
Apr 06, 2020
Laboratory of Neurogenetics and Neuroinflammation, Institut Imagine
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Mar 13, 2018
Undiagnosed Diseases Network, NIH
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.